AU521995B2 – 2-deoxyfortimicin a, 4-n-alkyl and 4-n-acyl-2 deoxyfortimicin b derivatives and intermediates therefor v’i
– Google Patents
AU521995B2 – 2-deoxyfortimicin a, 4-n-alkyl and 4-n-acyl-2 deoxyfortimicin b derivatives and intermediates therefor v’i
– Google Patents
2-deoxyfortimicin a, 4-n-alkyl and 4-n-acyl-2 deoxyfortimicin b derivatives and intermediates therefor v’i
Info
Publication number
AU521995B2
AU521995B2
AU41195/78A
AU4119578A
AU521995B2
AU 521995 B2
AU521995 B2
AU 521995B2
AU 41195/78 A
AU41195/78 A
AU 41195/78A
AU 4119578 A
AU4119578 A
AU 4119578A
AU 521995 B2
AU521995 B2
AU 521995B2
Authority
AU
Australia
Prior art keywords
deoxyfortimicin
acyl
derivatives
alkyl
intermediates therefor
Prior art date
1977-12-21
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU41195/78A
Other versions
AU4119578A
(en
Inventor
Jery Roy Martin And Paulette Collum John Soloman Gadamer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1977-12-21
Filing date
1978-10-31
Publication date
1982-05-13
1978-10-31
Application filed by Abbott Laboratories
filed
Critical
Abbott Laboratories
1980-05-08
Publication of AU4119578A
publication
Critical
patent/AU4119578A/en
1982-05-13
Application granted
granted
Critical
1982-05-13
Publication of AU521995B2
publication
Critical
patent/AU521995B2/en
Status
Expired
legal-status
Critical
Current
Links
Espacenet
Global Dossier
Discuss
Classifications
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
C07H15/20—Carbocyclic rings
C07H15/22—Cyclohexane rings, substituted by nitrogen atoms
C07H15/222—Cyclohexane rings substituted by at least two nitrogen atoms
C07H15/224—Cyclohexane rings substituted by at least two nitrogen atoms with only one saccharide radical directly attached to the cyclohexyl radical, e.g. destomycin, fortimicin, neamine
AU41195/78A
1977-12-21
1978-10-31
2-deoxyfortimicin a, 4-n-alkyl and 4-n-acyl-2 deoxyfortimicin b derivatives and intermediates therefor v’i
Expired
AU521995B2
(en)
Applications Claiming Priority (2)
Application Number
Priority Date
Filing Date
Title
US05/863,006
US4192867A
(en)
1977-12-21
1977-12-21
2-Deoxyfortimicin A, 4-N-alkyl and 4-N-acyl-2-deoxyfortimicin B derivatives
USUS863006
1977-12-21
Publications (2)
Publication Number
Publication Date
AU4119578A
AU4119578A
(en)
1980-05-08
AU521995B2
true
AU521995B2
(en)
1982-05-13
Family
ID=25339999
Family Applications (1)
Application Number
Title
Priority Date
Filing Date
AU41195/78A
Expired
AU521995B2
(en)
1977-12-21
1978-10-31
2-deoxyfortimicin a, 4-n-alkyl and 4-n-acyl-2 deoxyfortimicin b derivatives and intermediates therefor v’i
Country Status (10)
Country
Link
US
(2)
US4192867A
(en)
JP
(1)
JPS5490150A
(en)
AU
(1)
AU521995B2
(en)
CA
(1)
CA1123843A
(en)
DE
(1)
DE2855114A1
(en)
FR
(1)
FR2412563A1
(en)
GB
(1)
GB2010810B
(en)
GR
(1)
GR65189B
(en)
PH
(1)
PH16029A
(en)
SE
(1)
SE7812827L
(en)
Families Citing this family (9)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
JPS55164695A
(en)
*
1979-06-09
1980-12-22
Kowa Co
Novel aminoglycoside and its preparation
US4282211A
(en)
*
1979-09-26
1981-08-04
Abbott Laboratories
1-Epi-2-deoxyfortimicin B and derivatives
US4250304A
(en)
*
1979-09-26
1981-02-10
Abbott Laboratories
2-Deoxy-2-substituted fortimicin A and B and derivatives
US4252972A
(en)
*
1979-09-26
1981-02-24
Abbott Laboratories
Fortimicin B-1,2:4,5-bis-carbamates
US4263429A
(en)
*
1979-09-26
1981-04-21
Abbott Laboratories
1,2,6-Tri-N-benzyloxycarbonylfortimicin B-4,5-carbamate and 1,2,6-tri-N-acetylfortimicin B-4,5-carbamate
US7794713B2
(en)
*
2004-04-07
2010-09-14
Lpath, Inc.
Compositions and methods for the treatment and prevention of hyperproliferative diseases
US20090074720A1
(en)
*
2005-10-28
2009-03-19
Sabbadini Roger A
Methods for decreasing immune response and treating immune conditions
US20080213274A1
(en)
*
2005-10-28
2008-09-04
Sabbadini Roger A
Compositions and methods for the treatment and prevention of fibrotic, inflammatory, and neovascularization conditions of the eye
US7862812B2
(en)
*
2006-05-31
2011-01-04
Lpath, Inc.
Methods for decreasing immune response and treating immune conditions
Family Cites Families (3)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
US3931400A
(en)
*
1973-04-17
1976-01-06
Abbott Laboratories
Fortimicin B and process for production thereof
JPS5145675B2
(en)
*
1973-07-23
1976-12-04
US4169198A
(en)
*
1977-12-21
1979-09-25
Abbott Laboratories
2-Deoxyfortimicin B
1977
1977-12-21
US
US05/863,006
patent/US4192867A/en
not_active
Expired – Lifetime
1978
1978-10-24
CA
CA314,127A
patent/CA1123843A/en
not_active
Expired
1978-10-31
AU
AU41195/78A
patent/AU521995B2/en
not_active
Expired
1978-11-28
GR
GR57745A
patent/GR65189B/en
unknown
1978-12-04
PH
PH21874A
patent/PH16029A/en
unknown
1978-12-04
JP
JP14917578A
patent/JPS5490150A/en
active
Pending
1978-12-13
SE
SE7812827A
patent/SE7812827L/en
unknown
1978-12-20
DE
DE19782855114
patent/DE2855114A1/en
not_active
Withdrawn
1978-12-21
FR
FR7836000A
patent/FR2412563A1/en
active
Granted
1978-12-28
GB
GB7849392A
patent/GB2010810B/en
not_active
Expired
1981
1981-05-22
US
US06/266,266
patent/US4360668A/en
not_active
Expired – Fee Related
Also Published As
Publication number
Publication date
GB2010810A
(en)
1979-07-04
US4192867A
(en)
1980-03-11
SE7812827L
(en)
1979-06-22
GB2010810B
(en)
1982-12-22
CA1123843A
(en)
1982-05-18
AU4119578A
(en)
1980-05-08
FR2412563A1
(en)
1979-07-20
GR65189B
(en)
1980-07-29
US4360668A
(en)
1982-11-23
FR2412563B1
(en)
1982-07-09
DE2855114A1
(en)
1979-06-28
JPS5490150A
(en)
1979-07-17
PH16029A
(en)
1983-06-02
Similar Documents
Publication
Publication Date
Title
AU522538B2
(en)
1982-06-10
1, 2-benzothiazine-1, 1-dioxide derivatives
AU509680B2
(en)
1980-05-22
1,9-dihydroxyoctahydrophenanthrenes
AU521102B2
(en)
1982-03-18
2, 6-diaminonebularines
AU520250B2
(en)
1982-01-21
4-aminomethyl-1-93,3,3-triarylpropyl)-4-arylpiperidine and related compounds
AU521992B2
(en)
1982-05-13
N'phenyl-n-methyl-urea derivatives
AU513688B2
(en)
1980-12-18
1, l-disubstituted-3-heterocyclo urea derivatives
AU521995B2
(en)
1982-05-13
2-deoxyfortimicin a, 4-n-alkyl and 4-n-acyl-2 deoxyfortimicin b derivatives and intermediates therefor v'i
AU526584B2
(en)
1983-01-20
2,3-dicyanopyrazine derivatives
AU522588B2
(en)
1982-06-17
2'-n-acyl and alkyl-6'-n-alkyl and 6', 6'-di-n-alkyl derivatives of fortimicins a & b
AU3839678A
(en)
1980-01-31
Dibenzo(d,g) (1,3,6)dioxazocine derivatives
AU515140B2
(en)
1981-03-19
2, 4, 7-triamino-pteridine derivatives
AU524666B2
(en)
1982-09-30
3,4-methano pyrrolidine derivatives
AU527943B2
(en)
1983-03-31
2, 4-diamino-5-benzylpyrimidines
AU519292B2
(en)
1981-11-19
NEW 3-AMINO-17a azad-HOMOANDROSTONE DERIVATIVES
AU512608B2
(en)
1980-10-16
4'Homoisotwistane derivatives
AU535371B2
(en)
1984-03-15
3:,4: – dideoxykanamycin a and derivatives
AU518208B2
(en)
1981-09-17
2,4-dichlorophenyl-triazolyl-ethan-one and -ol derivatives
AU512413B2
(en)
1980-10-09
3. 4-Dihydro-quinazoline derivatives
AU518292B2
(en)
1981-09-24
1,4-benzoxathin-2-carboxamides
AU505664B2
(en)
1979-11-29
2, 1, 3-benzothiadiazoles
AU516080B2
(en)
1981-05-14
1, 2, 3-thiadiazolin-2-ide derivatives
AU515767B2
(en)
1981-04-30
Derivatives of 1, 3-diazafluorene
AU517889B2
(en)
1981-09-03
2, 6-METHANO-2H-l-BENZOXOCINS
AU524511B2
(en)
1982-09-23
Ribofuranosyl-imadazole derivatives and intermediates
AU516608B2
(en)
1981-06-11
Phenyl-2,3,4,5-tetrahydro-1h-3-benzazepine-7-8-dione derivatives
None